C4 Therapeutics Inc
Biotechnology
Healthcare
CCCC
69.63 M shares
NASDAQ US
traded
07 Apr 2025
listed
no
open
1.24
52 week high
7.38
high
1.34
52 week low
1.33
previous Close
1.38
P/E ratio
market cap
257 M
div yield
0
net incoming
-24.67 M
-39.23 %
net profit margin
-160.57 %
-13.00 %
operating incoming
-28.24 M
-31.72 %
net change in cash
-10.02 M
39.43 %
cash on hand
59.65 M
-18.42 %
cost of revenue
2.06 M
0.54 %
top